Cargando…

Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center

PURPOSE: Meibomian carcinoma is a rare and aggressive malignant neoplasm of the eyelids. The clinical presentation often mimics benign conditions thereby making the diagnosis challenging. The aim of the study was to analyze cases of meibomian carcinoma, the specimens of which were received, in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dasgupta, Senjuti, Jain, Parul, Bhattacharyya, Nirmal K., Khatoon, Rojina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846959/
https://www.ncbi.nlm.nih.gov/pubmed/36685345
http://dx.doi.org/10.4103/meajo.meajo_298_21
_version_ 1784871320299765760
author Dasgupta, Senjuti
Jain, Parul
Bhattacharyya, Nirmal K.
Khatoon, Rojina
author_facet Dasgupta, Senjuti
Jain, Parul
Bhattacharyya, Nirmal K.
Khatoon, Rojina
author_sort Dasgupta, Senjuti
collection PubMed
description PURPOSE: Meibomian carcinoma is a rare and aggressive malignant neoplasm of the eyelids. The clinical presentation often mimics benign conditions thereby making the diagnosis challenging. The aim of the study was to analyze cases of meibomian carcinoma, the specimens of which were received, in the past 2 years in the pathology department. METHODS: This retrospective observational study was undertaken for 2 years and included 9 patients of meibomian carcinoma. For each case, detailed history and clinical findings were retrieved from the hospital records. Histopathological examination was undertaken in all cases after preparing hematoxylin and eosin-stained slides from tissue blocks preserved in the department. RESULTS: The mean age of the patients was 55 ± 15 years. Six (66.7%) patients were females, and the other three (33.3%) were male. Following surgery, gross examination of the specimens revealed that the mean size of the excised tumors was 2.45 ± 1.45 cm. The tumors were classified based on histopathological features according to growth pattern, cell type, and cytoarchitecture. Most cases had lobular growth pattern (5, 55.6% cases), consisted of epidermoid cells (5, 55.6% cases), and exhibited infiltrative cytoarchitecture (8, 88.9% cases). CONCLUSION: Early diagnosis of meibomian carcinoma is important to reduce mortality from the aggressive tumor. The knowledge of clinicopathological aspects of the tumors that were biopsied in the department of pathology in the past 2 years will help in diagnosis and management of such tumors in future.
format Online
Article
Text
id pubmed-9846959
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98469592023-01-19 Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center Dasgupta, Senjuti Jain, Parul Bhattacharyya, Nirmal K. Khatoon, Rojina Middle East Afr J Ophthalmol Original Article PURPOSE: Meibomian carcinoma is a rare and aggressive malignant neoplasm of the eyelids. The clinical presentation often mimics benign conditions thereby making the diagnosis challenging. The aim of the study was to analyze cases of meibomian carcinoma, the specimens of which were received, in the past 2 years in the pathology department. METHODS: This retrospective observational study was undertaken for 2 years and included 9 patients of meibomian carcinoma. For each case, detailed history and clinical findings were retrieved from the hospital records. Histopathological examination was undertaken in all cases after preparing hematoxylin and eosin-stained slides from tissue blocks preserved in the department. RESULTS: The mean age of the patients was 55 ± 15 years. Six (66.7%) patients were females, and the other three (33.3%) were male. Following surgery, gross examination of the specimens revealed that the mean size of the excised tumors was 2.45 ± 1.45 cm. The tumors were classified based on histopathological features according to growth pattern, cell type, and cytoarchitecture. Most cases had lobular growth pattern (5, 55.6% cases), consisted of epidermoid cells (5, 55.6% cases), and exhibited infiltrative cytoarchitecture (8, 88.9% cases). CONCLUSION: Early diagnosis of meibomian carcinoma is important to reduce mortality from the aggressive tumor. The knowledge of clinicopathological aspects of the tumors that were biopsied in the department of pathology in the past 2 years will help in diagnosis and management of such tumors in future. Wolters Kluwer - Medknow 2022-11-23 /pmc/articles/PMC9846959/ /pubmed/36685345 http://dx.doi.org/10.4103/meajo.meajo_298_21 Text en Copyright: © 2022 Middle East African Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Dasgupta, Senjuti
Jain, Parul
Bhattacharyya, Nirmal K.
Khatoon, Rojina
Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center
title Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center
title_full Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center
title_fullStr Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center
title_full_unstemmed Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center
title_short Clinicopathological Study of Meibomian Carcinoma of Eyelids – An Experience of Two Years in a Tertiary Care Center
title_sort clinicopathological study of meibomian carcinoma of eyelids – an experience of two years in a tertiary care center
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846959/
https://www.ncbi.nlm.nih.gov/pubmed/36685345
http://dx.doi.org/10.4103/meajo.meajo_298_21
work_keys_str_mv AT dasguptasenjuti clinicopathologicalstudyofmeibomiancarcinomaofeyelidsanexperienceoftwoyearsinatertiarycarecenter
AT jainparul clinicopathologicalstudyofmeibomiancarcinomaofeyelidsanexperienceoftwoyearsinatertiarycarecenter
AT bhattacharyyanirmalk clinicopathologicalstudyofmeibomiancarcinomaofeyelidsanexperienceoftwoyearsinatertiarycarecenter
AT khatoonrojina clinicopathologicalstudyofmeibomiancarcinomaofeyelidsanexperienceoftwoyearsinatertiarycarecenter